Mental Health
Study Suggests Drug Abilify Delays Mania Relapse in Bipolar Disorder
Today, drug makers Bristol-Myers Squibb Company and Otsuka Pharmaceutical Company reported results of a 161-patient study that compared the time to relapse between patients who took the drug Abilify versus patients who received a placebo (”sugar pill”) for at least 6 weeks.
Compared with patients on placebo, those who took Abilify were 48% less likely to relapse into mania.
43% of the patients in the placebo group relapsed, versus 25% of the patients in the Abilify group.
Jane’s Note: While this study result is encouraging, the study is rather small, with only 161 patients.
Discussion
One comment for “Study Suggests Drug Abilify Delays Mania Relapse in Bipolar Disorder”
Post a comment
All information in Jane's Mental Health Source Page website is for your information and education. The information does not replace or substitute for professional medical treatment or for professional medical advice relative to a specific medical question or condition.
[...] Study Suggests Drug Abilify Delays Mania Relapse in Bipolar Disorder [...]